BACKGROUND: Cytochrome P450, family 11, subfamily A, polypeptide 1 (Cyp11a1), a cytochrome P450 enzyme, is the first and rate-limiting enzyme in the steroidogenic pathway, converting cholesterol to pregnenolone. Cyp11a1 expression is increased in activated T cells. OBJECTIVES: We sought to determine the role of Cyp11a1 activation in the development of peanut allergy and TH cell functional differentiation. METHODS: A Cyp11a1 inhibitor, aminoglutethimide (AMG), was administered to peanut-sensitized and challenged mice. Clinical symptoms, intestinal inflammation, and Cyp11a1 levels were assessed. The effects of Cyp11a1 inhibition on T(H)1, T(H)2, and T(H)17 differentiation were determined. Cyp11a1 gene silencing was performed with Cyp11a1-targeted short hairpin RNA. RESULTS: Peanut sensitization and challenge resulted in diarrhea, inflammation, and increased levels of Cyp11a1, IL13, and IL17A mRNA in the small intestine. Inhibition of Cyp11a1 with AMG prevented allergic diarrhea and inflammation. Levels of pregnenolone in serum were reduced in parallel. AMG treatment decreased IL13 and IL17A mRNA expression in the small intestine without affecting Cyp11a1 mRNA or protein levels. In vitro the inhibitor decreased IL13 and IL17A mRNA and protein levels in differentiated T(H)2 and T(H)17 CD4 T cells, respectively, without affecting GATA3, retinoic acid-related orphan receptor γt (RORγt), or T(H)1 cells and IFNG and T-bet expression. Short hairpin RNA-mediated silencing of Cyp11a1 in polarized T(H)2 CD4 T cells significantly decreased pregnenolone and IL13 mRNA and protein levels. CONCLUSION: Cyp11a1 plays an important role in the development of peanut allergy, regulating peanut-induced allergic responses through effects on steroidogenesis, an essential pathway in T(H)2 differentiation. Cyp11a1 thus serves as a novel target in the regulation and treatment of peanut allergy.
BACKGROUND: Cytochrome P450, family 11, subfamily A, polypeptide 1 (Cyp11a1), a cytochrome P450 enzyme, is the first and rate-limiting enzyme in the steroidogenic pathway, converting cholesterol to pregnenolone. Cyp11a1 expression is increased in activated T cells. OBJECTIVES: We sought to determine the role of Cyp11a1 activation in the development of peanutallergy and TH cell functional differentiation. METHODS: A Cyp11a1 inhibitor, aminoglutethimide (AMG), was administered to peanut-sensitized and challenged mice. Clinical symptoms, intestinal inflammation, and Cyp11a1 levels were assessed. The effects of Cyp11a1 inhibition on T(H)1, T(H)2, and T(H)17 differentiation were determined. Cyp11a1 gene silencing was performed with Cyp11a1-targeted short hairpin RNA. RESULTS:Peanut sensitization and challenge resulted in diarrhea, inflammation, and increased levels of Cyp11a1, IL13, and IL17A mRNA in the small intestine. Inhibition of Cyp11a1 with AMG prevented allergic diarrhea and inflammation. Levels of pregnenolone in serum were reduced in parallel. AMG treatment decreased IL13 and IL17A mRNA expression in the small intestine without affecting Cyp11a1 mRNA or protein levels. In vitro the inhibitor decreased IL13 and IL17A mRNA and protein levels in differentiated T(H)2 and T(H)17 CD4 T cells, respectively, without affecting GATA3, retinoic acid-related orphan receptor γt (RORγt), or T(H)1 cells and IFNG and T-bet expression. Short hairpin RNA-mediated silencing of Cyp11a1 in polarized T(H)2 CD4 T cells significantly decreased pregnenolone and IL13 mRNA and protein levels. CONCLUSION:Cyp11a1 plays an important role in the development of peanutallergy, regulating peanut-induced allergic responses through effects on steroidogenesis, an essential pathway in T(H)2 differentiation. Cyp11a1 thus serves as a novel target in the regulation and treatment of peanutallergy.
Authors: Catherine A Musselman; Julita Ramírez; Jennifer K Sims; Robyn E Mansfield; Samuel S Oliver; John M Denu; Joel P Mackay; Paul A Wade; James Hagman; Tatiana G Kutateladze Journal: Proc Natl Acad Sci U S A Date: 2012-01-03 Impact factor: 11.205
Authors: Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews Journal: N Engl J Med Date: 2011-08-03 Impact factor: 91.245
Authors: Gang Wei; Brian J Abraham; Ryoji Yagi; Raja Jothi; Kairong Cui; Suveena Sharma; Leelavati Narlikar; Daniel L Northrup; Qingsong Tang; William E Paul; Jinfang Zhu; Keji Zhao Journal: Immunity Date: 2011-08-26 Impact factor: 31.745
Authors: Jonathan H DeLong; Kelly Hetherington Simpson; Erik Wambre; Eddie A James; David Robinson; William W Kwok Journal: J Allergy Clin Immunol Date: 2011-04-02 Impact factor: 10.793
Authors: Silvia Parajes; Clemens Kamrath; Ian T Rose; Angela E Taylor; Christiaan F Mooij; Vivek Dhir; Joachim Grötzinger; Wiebke Arlt; Nils Krone Journal: J Clin Endocrinol Metab Date: 2011-08-31 Impact factor: 5.958
Authors: Meiqin Wang; Ivana V Yang; Elizabeth J Davidson; Anthony Joetham; Katsuyuki Takeda; Brian P O'Connor; Erwin W Gelfand Journal: J Allergy Clin Immunol Date: 2017-05-04 Impact factor: 10.793
Authors: Michaela Schedel; Yi Jia; Sven Michel; Katsuyuki Takeda; Joanne Domenico; Anthony Joetham; Fangkun Ning; Matthew Strand; Junyan Han; Meiqin Wang; Joseph J Lucas; Christian Vogelberg; Michael Kabesch; Brian P O'Connor; Erwin W Gelfand Journal: Nat Commun Date: 2016-01-11 Impact factor: 14.919
Authors: Sougata Roy; James Sipthorp; Bidesh Mahata; Jhuma Pramanik; Marco L Hennrich; Anne-Claude Gavin; Steven V Ley; Sarah A Teichmann Journal: iScience Date: 2021-04-28
Authors: Bidesh Mahata; Xiuwei Zhang; Aleksandra A Kolodziejczyk; Valentina Proserpio; Liora Haim-Vilmovsky; Angela E Taylor; Daniel Hebenstreit; Felix A Dingler; Victoria Moignard; Berthold Göttgens; Wiebke Arlt; Andrew N J McKenzie; Sarah A Teichmann Journal: Cell Rep Date: 2014-05-10 Impact factor: 9.423
Authors: Radomir M Slominski; Robert C Tuckey; Pulak R Manna; Anton M Jetten; Arnold Postlethwaite; Chander Raman; Andrzej T Slominski Journal: Genes Immun Date: 2020-03-23 Impact factor: 2.676